About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Terumo Shifts Focus from Oxymorphone Patch to Injectables
March 20, 2018
Click here to read more
Post navigation
Previous Post
Phosphagenics Placement Secures A$1.37 million
Next Post
Phosphagenics Newsletter – March 2018
Related Posts
CEO Quarterly Update
October 4, 2017
Podcast: Money News with Scott Haywood
November 27, 2023
November 27, 2023
Appendix 4E and 2016 Annual Financial Report
February 28, 2017